Back to dashboard
MedicaidCoverageMedium impact

Newsletter Vol. 4, No. 63

New Jersey Medicaid·NJ · Pharmacy·Provider Notice
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

New Jersey Medicaid has added 10 pharmaceutical manufacturers to its rebate program (including LNK International, InnerCare, Wide River Chemical, Jordan Pharmaceuticals, PRN Laboratories, Respa Pharmaceutical, Astra Merck, Nard Laboratories, Trinity Technologies, and Circa Pharmaceuticals) and deleted 2 manufacturers (Almay Inc and Auro Pharmaceuticals) from coverage. Drugs from deleted manufacturers will no longer be reimbursed by Medicaid effective the stated date.

Action Required

Action needed
Billing team must immediately update pharmacy claim submission systems to reflect manufacturer changes: (1) ADD to approved list: LNK International Inc, InnerCare, Wide River Chemical Inc, Jordan Pharmaceuticals Inc, PRN Laboratories Inc, Respa Pharmaceutical Inc, Astra Merck Group, Nard Laboratories Inc, Trinity Technologies Corporation, and Circa Pharmaceuticals Inc; (2) REMOVE from approved list and flag for denial: Almay Inc and Auro Pharmaceuticals Inc. Update formulary references and pharmacy benefits manager communications to reflect these changes. Inform providers and pharmacists that claims containing drugs from deleted manufacturers will be denied. Verify effective dates with NJ Medicaid program Chief Pharmaceutical Services as they are not clearly specified in this newsletter. Retain this document with other policy records for reference.

Related policy hubs